Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Drug Development Company

Drug Development Company Newsletter

Drug development company Inotiv reports ransomware attack to SEC 19 Aug 2025 13:28 GMT
An Indiana-based drug research company said a recent ransomware attack has disrupted its business operations and forced a shutdown of critical systems. Inotiv told regulators at the Securities Exchange Commission that the cybersecurity incident was …
US FDA grants fast track designation to AnnJi Pharma’s AJ201, a first-in-class therapy for Kenndy’s disease 24 Oct 2025 07:35 GMT
… Pharmaceutical Co., Ltd., clinical-stage drug development company focused on the development of … ., Ltd. is a clinical-stage drug development company focused on the development of …
ASX Runners of the Week: ASF Group, Vectus, Hawk Resources and Thor 24 Oct 2025 07:29 GMT
… Vectus Biosystems. The Melbourne-based drug development company shot up on news it …
New drug tested in mice could fill treatment void for most severe heart attack patients 24 Oct 2025 04:51 GMT
… USA sponsored by the Australian drug development company, Implicit Bioscience Ltd. Atibuclimab, a …
Novel Drug Could Fill Treatment Void For Most Severe Heart Attack Patients 23 Oct 2025 21:02 GMT
… USA sponsored by the Australian drug development company, Implicit Bioscience Ltd. Atibuclimab, a …
Takeda, Innovent Ink $11.4 Billion Cancer Drug Deal 23 Oct 2025 12:36 GMT
… antibody ADC with the new drug development company Canap Therapeutics.
FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy's Disease 23 Oct 2025 06:06 GMT
… : 7754) is a clinical-stage drug development company focused on the development of …
AI robotic drug development company Persist AI raises $12 million 22 May 2025 03:46 GMT
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million 22 Oct 2025 11:00 GMT
… Biossil is an AI-native drug development company advancing a pipeline of late …
Drug development company lands £1.1m boost marking “significant milestone” 11 Apr 2025 11:11 GMT
A Newcastle-based drug development company has secured a £1.1m …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS